Authors reported, “Except for self-perceived dysfunctional cannabis use, the association between cannabis use with an increased risk of adverse health outcomes was not observed in the present study.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Researchers concluded, “The lack of relationship between blood THC concentration and driving performance raises questions about the validity of per se laws.”
Over 70 percent of respondents said that the “lack of access to banking or investment capital” was their top challenge and only 40 percent believe that “the industry is heading in the right direction.”
The initiation of cannabis products “led to a significant decrement in chronic opioid use for the majority” of chronic pain patients participating in the trial.
An even greater majority of those polled said that they did not expect the President to take any substantive action on the issue in 2022.
Investigators concluded, “Medical cannabis can be an effective and safe treatment for BEB.”
Authors concluded, “[I]t is increasingly clear that … the effects of widespread cannabis use will not necessarily mirror the harms caused by tobacco smoking.”
New Hampshire: Supreme Courts Rules in Favor of Employment Protections for Medical Cannabis Patients
Justices ruled that providing the defendant with an exception to a company’s marijuana drug testing policy was a “reasonable accommodation” under state law.